Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 64 results.
User Information
Export Records
  1. 1.   ERK phosphorylation is dependent on cell adhesion in a subset of pediatric sarcoma cell lines
  2. Yoon, Hye-Young; Maron, Ben Y; Girald-Berlingeri, Sofia; Gasilina, Anjelika; Gollin, Josephine C; Jian, Xiaoying; Akpan, Itoro; Yohe,Marielle; Randazzo, Paul A; Chen, Pei-Wen
  3. Biochimica et Biophysica Acta. Molecular Cell Research. 2022, Apr 03; 1869(8):
  1. 2.   TET2 and DNMT3A mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models
  2. Yang, Sherry X; Hollingshead, Melinda; Rubinstein, Larry; Nguyen, Dat; Larenjeira, Angelo B A; Kinders,Robert; Difilippantonio, Michael; Doroshow, James H
  3. Journal of Hematology & Oncology. 2021, May 26; 14(1):
  1. 3.   Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse
  2. Su, Hao; Zhu, Guangzhi; Djaja P, Ketut Indra; Lin, Yi; Gong, Yizhen; Liu, Xiaoguang; Li, Jiaquan; Liu, Zhiming; Qin, Xiao; Li, Lequn; Liu, Tangwei; Lu, Zili; Wei, Minyi; Yan, Lunan; Winkler, Cheryl; O'Brien, Stephen J; Li, Jing; Xiao, Kaiyin; Peng, Tao
  3. Oncotarget. 2017, Aug 15; 8(33): 54402-54415.
  1. 4.   Farnesylated and methylated KRAS4b: high yield production of protein suitable for biophysical studies of prenylated protein-lipid interactions
  2. Gillette, W. K.; Esposito, D.; Abreu Blanco, M.; Alexander, P.; Bindu, L.; Bittner, C.; Chertov, O.; Frank, P. H.; Grose, C.; Jones, J. E.; Meng, Z.; Perkins, S.; Van, Q.; Ghirlando, R.; Fivash, M.; Nissley, D. V.; McCormick, F.; Holderfield, M.; Stephen, A. G.
  3. Scientific Reports. 2015 5: 15916.
  1. 5.   Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2
  2. Huang, W. Y.; Yang, P. M.; Chang, Y. F.; Marquez, V. E.; Chen, C. C.
  3. Biochemical Pharmacology. 2011, Feb; 81(4): 510-517.
  1. 6.   miRNA-7 Attenuation in Schwannoma Tumors Stimulates Growth by Upregulating Three Oncogenic Signaling Pathways
  2. Saydam, O.; Senol, O.; Wurdinger, T.; Mizrak, A.; Ozdener, G. B.; Stemmer-Rachamimov, A. O.; Yi, M.; Stephens, R. M.; Krichevsky, A. M.; Saydam, N.; Brenner, G. J.; Breakefield, X. O.
  3. Cancer Research. 2011, Feb; 71(3): 852-861.
  1. 7.   Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations
  2. Yang, X. R.; Liang, X. Y.; Pfeiffer, R. M.; Wheeler, W.; Maeder, D.; Burdette, L.; Yeager, M.; Chanock, S.; Tucker, M. A.; Goldstein, A. M.
  3. Familial Cancer. 2010, Dec; 9(4): 625-633.
  1. 8.   Epimorphic regeneration in mice is p53-independent
  2. Arthur, L. M.; Demarest, R. M.; Clark, L.; Gourevitch, D.; Bedelbaeva, K.; Anderson, R.; Snyder, A.; Capobianco, A. J.; Lieberman, P.; Feigenbaum, L.; Heber-Katz, E.
  3. Cell Cycle. 2010, Sep; 9(18): 3667-3673.
  1. 9.   Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer
  2. Senchenko, V. N.; Anedchenko, E. A.; Kondratieva, T. T.; Krasnov, G. S.; Dmitriev, A. A.; Zabarovska, V. I.; Pavlova, T. V.; Kashuba, V. I.; Lerman, M. I.; Zabarovsky, E. R.
  3. Bmc Cancer. 2010, Mar; 10: 13.
  1. 10.   A dual role of Cdk2 in DNA damage response
  2. Satyanarayana, A.; Kaldis, P.
  3. Cell Division. 2009, May; 4: 4.
  1. 11.   Cdk2 and Cdk4 Activities Are Dispensable for Tumorigenesis Caused by the Loss of p53
  2. Padmakumar, V. C.; Aleem, E.; Berthet, C.; Hilton, M. B.; Kaldis, P.
  3. Molecular and Cellular Biology. 2009 29(10): 2582-2593.
  1. 12.   HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
  2. Wang, F. L.; Grigorieva, E. V.; Li, J. F.; Senchenko, V. N.; Pavlova, T. V.; Anedchenko, E. A.; Kudryavtseva, A. V.; Tsimanis, A.; Angeloni, D.; Lerman, M. I.; Kashuba, V. I.; Klein, G.; Zabarovsky, E. R.
  3. Plos One. 2008, Aug; 3(8): 8.
  1. 13.   Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist
  2. Giubellino, A.; Shi, Z. D.; Jenkins, L.; Worthy, K. M.; Bindu, L. K.; Athauda, G.; Peruzzi, B.; Fisher, R. J.; Appella, E.; Burke, T. R.; Bottaro, D. P.
  3. Journal of Medicinal Chemistry. 2008 51(23): 7459-7468.
  1. 14.   Mechanism of the chemical step for the guanosine triphosphate (GTP) hydrolysis catalyzed by elongation factor Tu
  2. Grigorenko, B. L.; Shadrina, M. S.; Topol, I. A.; Collins, J. R.; Nemukhin, A. V.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2008 1784(12): 1908-1917.
  1. 15.   Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours
  2. Ivanova, A. V.; Vortmeyer, A.; Ivanov, S. V.; Nickerson, M. L.; Maher, E. R.; Lerman, M. I.
  3. Journal of Pathology. 2008 214(1): 46-57.
  1. 16.   Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage
  2. Lo, P. H. Y.; Xie, D.; Chan, K. C.; Xu, F. P.; Kuzmin, I.; Lerman, M. I.; Law, S.; Chua, D.; Sham, J.; Lung, M. L.
  3. Cancer Letters. 2007, Nov; 257(2): 199-205.
  1. 17.   Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter
  2. Angeloni, D.; Danilkovitch-Miagkova, A.; Ivanova, T.; Braga, E.; Zabarovsky, E.; Lerman, M. I.
  3. Oncogene. 2007, Jul; 26(31): 4499-4512.
  1. 18.   Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations
  2. Grigorenko, B. L.; Nemukhin, A. V.; Shadrina, M. S.; Topol, I. A.; Burt, S. K.
  3. Proteins-Structure Function and Bioinformatics. 2007, Feb; 66(2): 456-466.
  1. 19.   Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma
  2. Yau, W. L.; Lung, H. L.; Zabarovsky, E. R.; Lerman, M. I.; Sham, J. S. T.; Chua, D. T. T.; Tsao, S. W.; Stanbridge, E. J.; Lung, M. L.
  3. International Journal of Cancer. 2006, Dec; 119(12): 2821-2826.
  1. 20.   Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas
  2. Lo, P. H. Y.; Leung, A. C. C.; Xiong, W. J.; Law, S.; Duh, F. M.; Lerman, M. I.; Stanbridge, E. J.; Lung, M. L.
  3. Cancer Letters. 2006, Mar; 234(2): 184-192.
  1. 21.   P205, A potential, tumor suppressor, inhibits cell proliferation via multiple pathways of cell cycle regulation
  2. Asefa, B.; Dermott, J. M.; Kaldis, P.; Stefanisko, K.; Garfinkel, D. J.; Keller, J. R.
  3. Febs Letters. 2006, Feb; 580(5): 1205-1214.
  1. 22.   Comprehensive analysis of CDKN2A (p16(INK4A)/p14(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
  2. Laud, K.; Marian, C.; Avril, M. F.; Barrois, M.; Chompret, A.; Goldstein, A. M.; Tucker, M. A.; Clark, P. A.; Peters, G.; Chaudru, V.; Demenais, F.; Spatz, A.; Smith, M. W.; Lenoir, G. M.; Bressac-de Paillerets, B.; French Hereditary Melanoma Study, G.
  3. Journal of Medical Genetics. 2006, Jan; 43(1): 39-47.
  1. 23.   The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
  2. Nagl, N. G.; Patsialou, A.; Haines, D. S.; Dallas, P. B.; Beck, G. R.; Moran, E.
  3. Cancer Research. 2005, OCT 15; 65(20): 9236-9244.
  1. 24.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 25.   5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation
  2. Catalano, A.; Rodilossi, S.; Caprari, P.; Coppola, V.; Procopio, A.
  3. Embo Journal. 2005, JAN 12; 24(1): 170-179.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel